Insulin Delivery Device Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (Tethered, Tubeless), Insulin Pen Needle (Standard, Safety), Insulin Syringes, Others), Disease Type (Type 1 Diabetes, Type 2 Diabetes)

Description

List of Tables

The global insulin delivery devices market is projected to reach USD 52.7 billion by 2030 from USD 35.3 billion in 2025, at a CAGR of 8.3% during the forecast period. The insulin delivery devices market is experiencing consistent growth due to several factors. As the global population ages, the prevalence of conditions like diabetes is rising, leading to an increased demand for advanced insulin delivery devices. Additionally, government support and favorable reimbursement schemes are further promoting market growth.

Scope of the Report
Years Considered for the Study	2024-2030
Base Year	2024
Forecast Period	2024-2030
Units Considered	Value (USD billion)
Segments	Type, Disease Type, End User, and Region
Regions covered	North America, Europe, Asia Pacific, Middle East & Africa, and Latin America

Technological advancements in insulin delivery devices, such as the integration of artificial intelligence (AI) and machine learning (ML), have also contributed to this demand. Furthermore, an increase in research and development activities, along with strategic partnerships, is creating additional opportunities for growth in the market.

Overall, the rise in healthcare expenditure focused on diabetes care, combined with the increasing prevalence of diabetes, is fostering new opportunities for market expansion.

The reusable insulin pens segment accounted for the largest share of the insulin delivery devices market, by type of insulin pen, in 2024.

The insulin delivery devices market can be categorized into several types: insulin pens, insulin pumps, insulin syringes, insulin pen needles, and other insulin delivery devices. Within the category of insulin pens, there are two main types: reusable insulin pens and disposable insulin pens. As of 2024, reusable insulin pens held the largest market share.

Reusable insulin pens feature a delivery chamber designed to hold prefilled insulin cartridges. These devices are more cost-effective than disposable insulin pens, leading to their increasing popularity for insulin delivery. They provide significant advantages in terms of affordability, sustainability, and user-friendliness. Additionally, reusable pens offer environmental benefits.

A recent study from the University of Exeter in 2024 reported that approximately four million single-use insulin pens are prescribed annually in England, resulting in about 79 tons of plastic waste and emitting 1,000 tons of carbon dioxide, which is equivalent to the emissions from 250 additional cars on the road. In contrast, reusable insulin pens can significantly reduce this waste, making them a more sustainable option. Consequently, a growing number of end users are opting for reusable insulin pens, driving the segment's growth.

In 2024, the home care settings segment held the largest share of the insulin delivery devices market.

The insulin delivery devices market is categorized by end users into home care settings, hospitals & clinics, and other end users. In 2024, the home care settings segment held the largest market share. This trend is primarily attributed to the increasing preference for self-administration of insulin among patients. One of the main advantages of self-administration is the time and cost savings it offers, as patients can avoid the need for regular visits to healthcare providers for insulin administration. Additionally, self-administration can enhance medication adherence and improve treatment outcomes.

Several factors support this trend, including the launch of advanced, user-friendly delivery devices, manufacturers' focus on providing patient training, and the availability of reimbursements for insulin self-administration in key markets. Over the years, the market has also seen the introduction of technologically advanced pumps and pen needles designed to help patients manage diabetes through self-administration. These new products are designed to deliver precise amounts of insulin using minimally invasive techniques. Collectively, these factors are driving growth in this segment of the market.

In 2024, North America accounted for the largest share of the insulin delivery devices market.

The global market for insulin delivery devices is divided into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2024, North America accounted for the largest share of this market, primarily due to the rising prevalence of type 1 diabetes in the region. Since type 1 diabetes is dependent on insulin, the increasing number of diabetes patients is driving up demand for insulin delivery devices.

According to the International Diabetes Federation (IDF) Atlas 2025, approximately 1.4 million individuals in the US and 240,000 in Canada were reported to be living with type 1 diabetes in 2024. This growing patient population is fueling a continuous demand for various insulin delivery devices, including pens, pumps, syringes, and pen needles.

Additionally, the North American region is witnessing significant investments in research and development aimed at enhancing insulin delivery technologies. Companies in the area are actively working to improve patient convenience, accuracy, and connectivity of these devices to meet the evolving needs of healthcare professionals and patients. The combination of high disease prevalence, technological advancements, and a robust healthcare infrastructure ensures that North America remains a leading region in the global insulin delivery devices market.

A breakdown of the primary participants referred to for this report is provided below:

By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
By Designation: C-level Executives (50%), Director-level Executives (30%), and Others (20%)
By Region: North America (30%), Europe (25%), Asia Pacific (20%), Latin America (15%), and the Middle East & Africa (10%)

Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10 billion, Tier 2 = USD 1 billion to USD 10 billion, and Tier 3 = <USD 1 billion.

Note 2: C-level executives include CEOs, CFOs, COOs, and VPs.

Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The players operating in the insulin delivery devices market include Embecta Corp.(US), Novo Nordisk A/S (Denmark), Ypsomed (Switzerland), Medtronic (Ireland), Tandem Diabetes Care, Inc. (US), Sanofi (France), and Eli Lilly and Company (US), Tandem Diabetes Care, Inc. (US), Insulet Corporation (US), Biocon (India), Roche Diabetes Care (Switzerland), HTL-STREFA, a subsidiary of the MTD Group (Poland), Ypsomed (Switzerland), Medtrum Technologies Inc. (China), Terumo Corporation (Japan), Wockhardt Limited (India), Nipro (Japan), Cequr Corporation (Switzerland), Eoflow Co., Ltd. (South Korea), Hindustan Syringes & Medical Devices Ltd. (India), SOOIL Developments Co., Ltd. (South Korea), SUNGSHIM MEDICAL CO., LTD (South Korea), B. Braun SE (Germany), Debiotech SA (Switzerland), Jiangsu Delfu Medical Device Co., Ltd. (China), Haselmeier, a Medmix company (Germany), and Mankind Corporation (US).

Research Coverage

This report studies the insulin delivery devices market based on type, disease type, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will allow both established companies and smaller or new firms to assess market trends, helping them increase their market share. Companies that purchase the report can employ one or more of the strategies outlined below to enhance their market presence.

This report provides insights on the following pointers:

Analysis of key drivers (growing prevalence of diabetes, technological advancements in insulin delivery devices, government support, and favorable reimbursement schemes), restraints (high cost and lack of reimbursement in developing countries, needle anxiety in patients, and alternative drug delivery methods), opportunities (increasing research and development activities and strategic partnerships, increasing healthcare expenditure on diabetes care, advances in syringe and needle technology, and mandates pertaining to safety-engineered medical needles), challenges (needlestick injuries and misuse of injection pens and lack of interoperability among insulin delivery devices)
Market Penetration: Complete knowledge of the spectrum of products presented by the major companies in the insulin delivery devices market
Product Development/Innovation: Comprehensive understanding of the forthcoming trends, research and development initiatives, and product launches within the insulin delivery devices market
Market Development: Complete knowledge about profitable developing regions
Market Diversification: Exhaustive knowledge of new goods, expanding geographies, and current changes in the insulin delivery devices industry helps to diversify the market
Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like Embecta Corp. (US), Novo Nordisk A/S (Denmark), Ypsomed (Switzerland), Medtronic (Ireland), Tandem Diabetes Care, Inc. (US), Sanofi (France), and Eli Lilly and Company (US)

Product Code: MD 5192

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
- 1.3.1 STUDY INCLUSIONS AND EXCLUSIONS
- 1.3.2 MARKETS COVERED
- 1.3.3 YEARS CONSIDERED FOR STUDY
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
  - 2.1.1.1 Key data from secondary sources
- 2.1.2 PRIMARY DATA
  - 2.1.2.1 Key data from primary sources
  - 2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR STUDY
2.6 RESEARCH LIMITATIONS
- 2.6.1 SCOPE-RELATED LIMITATIONS
- 2.6.2 METHODOLOGY-RELATED LIMITATIONS
2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 INSULIN DELIVERY DEVICES: MARKET OVERVIEW
4.2 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE AND COUNTRY
4.3 INSULIN DELIVERY DEVICES MARKET: GEOGRAPHICAL MIX
4.4 INSULIN DELIVERY DEVICES MARKET: REGIONAL MIX
4.5 INSULIN DELIVERY DEVICES MARKET: DEVELOPED VS. DEVELOPING MARKETS

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
  - 5.2.1.1 Growth in prevalence of diabetic population
  - 5.2.1.2 Technological advancements in insulin delivery devices
  - 5.2.1.3 Government support and favorable reimbursement schemes to favor the market growth
- 5.2.2 RESTRAINTS
  - 5.2.2.1 High cost and lack of reimbursement in emerging economies
  - 5.2.2.2 Needle anxiety in patients to affect growth of pen needles and syringes market
  - 5.2.2.3 Oral insulin as alternative drug delivery method
- 5.2.3 OPPORTUNITIES
  - 5.2.3.1 Increase in research & development activities and strategic partnerships
  - 5.2.3.2 Increase in healthcare expenditure on diabetes care
  - 5.2.3.3 Advances in insulin syringe and needle technology
  - 5.2.3.4 Mandates pertaining to safety-engineered medical needles
- 5.2.4 CHALLENGES
  - 5.2.4.1 Needlestick injuries and misuse of injection pens
  - 5.2.4.2 Lack of interoperability among insulin delivery devices
5.3 REGULATORY ANALYSIS
- 5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.3.2 REGULATORY FRAMEWORK
  - 5.3.2.1 North America
    - 5.3.2.1.1 US
    - 5.3.2.1.2 Canada
  - 5.3.2.2 Europe
  - 5.3.2.3 Asia Pacific
    - 5.3.2.3.1 Japan
    - 5.3.2.3.2 China
    - 5.3.2.3.3 India
    - 5.3.2.3.4 Australia
  - 5.3.2.4 Latin America
    - 5.3.2.4.1 Brazil
    - 5.3.2.4.2 Mexico
  - 5.3.2.5 Middle East
  - 5.3.2.6 Africa
5.4 INDUSTRY TRENDS
- 5.4.1 GROWING DEMAND FOR HYBRID CLOSED-LOOP SYSTEMS/ARTIFICIAL PANCREAS DEVICE SYSTEMS
- 5.4.2 SYNCHRONIZATION OF SMART INSULIN PENS WITH CONTINUOUS GLUCOSE MONITORING SYSTEMS PROMOTES DIABETES DATA SHARING
- 5.4.3 INCREASE IN NUMBER OF COLLABORATIONS AMONG STAKEHOLDERS
5.5 REIMBURSEMENT SCENARIO
- 5.5.1 GLOBAL COVERAGE AND REIMBURSEMENT
5.6 TECHNOLOGY ANALYSIS
5.7 TECHNOLOGY ANALYSIS
- 5.7.1 KEY TECHNOLOGIES
  - 5.7.1.1 Automated insulin delivery
- 5.7.2 COMPLEMENTARY TECHNOLOGIES
  - 5.7.2.1 Bluetooth
- 5.7.3 ADJACENT TECHNOLOGIES
  - 5.7.3.1 Continuous glucose monitoring
5.8 KEY CONFERENCES & EVENTS
5.9 PRICING ANALYSIS
- 5.9.1 INDICATIVE PRICING TREND OF INSULIN DELIVERY DEVICE, BY KEY PLAYER
- 5.9.2 INDICATIVE PRICING TREND OF INSULIN DELIVERY DEVICE, BY REGION
5.10 TRADE ANALYSIS
5.11 PATENT ANALYSIS
- 5.11.1 PATENT PUBLICATION TRENDS FOR INSULIN DELIVERY DEVICES
- 5.11.2 JURISDICTION ANALYSIS: TOP APPLICANTS FOR PATENTS IN INSULIN DELIVERY DEVICES MARKET
5.12 SUPPLY CHAIN ANALYSIS
5.13 VALUE CHAIN ANALYSIS
5.14 ECOSYSTEM MARKET MAP
5.15 CASE STUDY ANALYSIS
- 5.15.1 OMNIPOD 5 FACILITATED EFFECTIVE INSULIN MANAGEMENT FOR YOUNG ATHLETES, SUPPORTING CONTINUITY IN TRAINING AND COMPETITION
- 5.15.2 MEDTRONIC MINIMED INSULIN PUMP ENHANCED GLUCOSE CONTROL, IMPROVING DAILY MANAGEMENT FOR PEOPLE WITH DIABETES
- 5.15.3 SMART INSULIN DELIVERY WITH MEDTRONIC INPEN FOR IMPROVED DIABETES MANAGEMENT
5.16 PORTER'S FIVE FORCES ANALYSIS
- 5.16.1 INTENSITY OF COMPETITIVE RIVALRY
- 5.16.2 BARGAINING POWER OF SUPPLIERS
- 5.16.3 BARGAINING POWER OF BUYERS
- 5.16.4 THREAT OF SUBSTITUTES
- 5.16.5 THREAT OF NEW ENTRANTS
5.17 KEY STAKEHOLDERS AND BUYING CRITERIA
- 5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.17.2 BUYING CRITERIA
5.18 ADJACENT MARKET ANALYSIS
5.19 INVESTMENT & FUNDING SCENARIO
5.20 UNMET NEEDS/END-USER EXPECTATIONS IN INSULIN DELIVERY DEVICES MARKET
5.21 TRENDS/DISRUPTION IMPACTING CUSTOMER'S BUSINESS
5.22 IMPACT OF AI/GENERATIVE AI ON INSULIN DELIVERY DEVICES MARKET

6 INSULIN DELIVERY DEVICES MARKET, BY TYPE

6.1 INTRODUCTION
6.2 INSULIN PENS
- 6.2.1 ADVANCED AND CONVENIENT SOLUTIONS FOR INSULIN ADMINISTRATION TO DRIVE MARKET
- 6.2.2 REUSABLE INSULIN PENS
  - 6.2.2.1 Technology innovations offering cost-effectiveness to boost growth
- 6.2.3 DISPOSABLE INSULIN PENS
  - 6.2.3.1 Ease of use to drive market, though shift toward eco-friendly environment can challenge growth
6.3 INSULIN PUMPS
- 6.3.1 PRECISION OFFERED BY NEWER AND MORE REFINED TECHNOLOGY TO DRIVE INSULIN PUMPS MARKET
- 6.3.2 TETHERED INSULIN PUMPS
  - 6.3.2.1 Increase in collaborations and partnerships between companies to develop integrated CGM systems to drive market
- 6.3.3 TUBELESS INSULIN PUMPS
  - 6.3.3.1 Use of artificial intelligence and technological advancements to boost market
6.4 INSULIN PEN NEEDLES
- 6.4.1 STANDARD INSULIN PEN NEEDLES
  - 6.4.1.1 Affordability of standard insulin pen needles over safety pen needles to propel growth
- 6.4.2 SAFETY INSULIN PEN NEEDLES
  - 6.4.2.1 Reduced chances of infection and accidental pricking to drive market
6.5 INSULIN SYRINGES
- 6.5.1 COMMONLY USED DELIVERY MEANS CHALLENGED BY SAFETY CONCERNS AND AWARENESS OF AFFORDABLE ALTERNATIVES
6.6 OTHER INSULIN DELIVERY DEVICES

7 INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE

7.1 INTRODUCTION
7.2 TYPE 1 DIABETES
- 7.2.1 CHRONIC NATURE OF TYPE 1 DIABETES, COMBINED WITH SIGNIFICANT INCIDENCE IN CHILDREN AND YOUNG ADULTS, TO DRIVE GROWTH
7.3 TYPE 2 DIABETES
- 7.3.1 RISING PREVALENCE OF TYPE 2 DIABETES, DRIVEN BY LIFESTYLE-RELATED RISK FACTORS AND EARLIER DISEASE ONSET TO FUEL MARKET

8 INSULIN DELIVERY DEVICES MARKET, BY END USER

8.1 INTRODUCTION
8.2 HOME CARE SETTINGS
- 8.2.1 INCREASE IN AFFORDABILITY OF SELF-MONITORING SYSTEMS AND INSULIN DELIVERY DEVICES TO FUEL SELF/HOME HEALTHCARE
8.3 HOSPITALS & CLINICS
- 8.3.1 RISE IN DEMAND FOR POINT-OF-CARE TESTING IN HOSPITALS TO BOOST MARKET GROWTH
8.4 OTHER END USERS

9 INSULIN DELIVERY DEVICES MARKET, BY REGION

9.1 INTRODUCTION
9.2 NORTH AMERICA
- 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 9.2.2 US
  - 9.2.2.1 Largest share of North American insulin delivery device market
- 9.2.3 CANADA
  - 9.2.3.1 Rise in government support to boost market in Canada
9.3 EUROPE
- 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 9.3.2 GERMANY
  - 9.3.2.1 Germany to dominate European insulin delivery devices market
- 9.3.3 UK
  - 9.3.3.1 Government support and research funding to drive market growth in UK
- 9.3.4 FRANCE
  - 9.3.4.1 High insurance coverage and increasing affordability to fuel market
- 9.3.5 ITALY
  - 9.3.5.1 Increase in government spending to drive insulin delivery device growth in Italy
- 9.3.6 SPAIN
  - 9.3.6.1 Minimal co-payments and full reimbursement to drive market growth in Spain
- 9.3.7 REST OF EUROPE (ROE)
9.4 ASIA PACIFIC
- 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 9.4.2 CHINA
  - 9.4.2.1 China to dominate Asia Pacific's insulin delivery devices market
- 9.4.3 JAPAN
  - 9.4.3.1 Rise in aging population and high diabetes cases to drive growth in Japan
- 9.4.4 INDIA
  - 9.4.4.1 Rise in diabetes cases and affordable local manufacturing to fuel insulin device demand in India
- 9.4.5 AUSTRALIA
  - 9.4.5.1 Government subsidies to support market growth
- 9.4.6 SOUTH KOREA
  - 9.4.6.1 Rise in diabetes cases and strong government healthcare support to boost market
- 9.4.7 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
- 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 9.5.2 BRAZIL
  - 9.5.2.1 Brazil to account for largest share in Latin American insulin delivery devices market
- 9.5.3 MEXICO
  - 9.5.3.1 Growth in regulatory support to propel market
- 9.5.4 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
- 9.6.1 MACROECONOMIC OUTLOOK FOR THE MIDDLE EAST & AFRICA
- 9.6.2 GCC COUNTRIES
  - 9.6.2.1 Rise in diabetes prevalence and high per capita healthcare expenditure to drive market in GCC countries
- 9.6.3 REST OF THE MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

10.1 INTRODUCTION
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN INSULIN DELIVERY DEVICES MARKET
10.3 REVENUE ANALYSIS, 2022-2024
10.4 MARKET SHARE ANALYSIS, 2024
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
- 10.5.1 STARS
- 10.5.2 EMERGING LEADERS
- 10.5.3 PERVASIVE PLAYERS
- 10.5.4 PARTICIPANTS
- 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
  - 10.5.5.1 Company footprint
  - 10.5.5.2 Type footprint
  - 10.5.5.3 Region footprint
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
- 10.6.1 PROGRESSIVE COMPANIES
- 10.6.2 RESPONSIVE COMPANIES
- 10.6.3 DYNAMIC COMPANIES
- 10.6.4 STARTING BLOCKS
- 10.6.5 COMPETITIVE BENCHMARKING
  - 10.6.5.1 DETAILED LIST OF KEY STARTUPS/SMES, 2024
  - 10.6.5.2 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
10.7 BRAND/PRODUCT COMPARISON
10.8 COMPANY VALUATION & FINANCIAL METRICS
- 10.8.1 FINANCIAL METRICS
- 10.8.2 COMPANY VALUATION
10.9 R&D ASSESSMENT OF KEY PLAYERS
10.10 COMPETITIVE SCENARIO
- 10.10.1 PRODUCT LAUNCHES & APPROVALS
- 10.10.2 DEALS
- 10.10.3 EXPANSIONS
- 10.10.4 OTHER DEVELOPMENTS

11 COMPANY PROFILES

11.1 KEY PLAYERS
- 11.1.1 EMBECTA CORP. (FORMERLY BECTON, DICKINSON AND COMPANY DIABETES CARE BUSINESS)
  - 11.1.1.1 Business overview
  - 11.1.1.2 Products offered
  - 11.1.1.3 Recent developments
    - 11.1.1.3.1 Product launches and approvals
    - 11.1.1.3.2 Deals
    - 11.1.1.3.3 Expansions
    - 11.1.1.3.4 Other developments
  - 11.1.1.4 MnM view
    - 11.1.1.4.1 Right to win
    - 11.1.1.4.2 Strategic choices
    - 11.1.1.4.3 Weaknesses & competitive threats
- 11.1.2 NOVO NORDISK A/S
  - 11.1.2.1 Business overview
  - 11.1.2.2 Products offered
  - 11.1.2.3 Recent developments
    - 11.1.2.3.1 Product launches and approvals
    - 11.1.2.3.2 Deals
    - 11.1.2.3.3 Other developments
  - 11.1.2.4 MnM view
    - 11.1.2.4.1 Right to win
    - 11.1.2.4.2 Strategic choices
    - 11.1.2.4.3 Weaknesses & competitive threats
- 11.1.3 MEDTRONIC
  - 11.1.3.1 Business overview
  - 11.1.3.2 Products offered
  - 11.1.3.3 Recent developments
    - 11.1.3.3.1 Product launches and approvals
    - 11.1.3.3.2 Deals
    - 11.1.3.3.3 Expansions
    - 11.1.3.3.4 Other developments
  - 11.1.3.4 MnM view
    - 11.1.3.4.1 Right to win
    - 11.1.3.4.2 Strategic choices
    - 11.1.3.4.3 Weaknesses & competitive threats
- 11.1.4 SANOFI
  - 11.1.4.1 Business overview
  - 11.1.4.2 Products offered
  - 11.1.4.3 Recent developments
    - 11.1.4.3.1 Product launches and approvals
    - 11.1.4.3.2 Expansions
    - 11.1.4.3.3 Other developments
  - 11.1.4.4 MnM view
    - 11.1.4.4.1 Right to win
    - 11.1.4.4.2 Strategic choices
    - 11.1.4.4.3 Weaknesses & competitive threats
- 11.1.5 ELI LILLY AND COMPANY
  - 11.1.5.1 Business overview
  - 11.1.5.2 Products offered
  - 11.1.5.3 Recent developments
    - 11.1.5.3.1 Product launches and approvals
    - 11.1.5.3.2 Deals
    - 11.1.5.3.3 Expansions
    - 11.1.5.3.4 Other developments
  - 11.1.5.4 MnM view
    - 11.1.5.4.1 Right to win
    - 11.1.5.4.2 Strategic choices
    - 11.1.5.4.3 Weaknesses and competitive threats
- 11.1.6 TANDEM DIABETES CARE, INC.
  - 11.1.6.1 Business overview
  - 11.1.6.2 Products offered
  - 11.1.6.3 Recent developments
    - 11.1.6.3.1 Product launches and approvals
    - 11.1.6.3.2 Deals
- 11.1.7 INSULET CORPORATION
  - 11.1.7.1 Business overview
  - 11.1.7.2 Products offered
  - 11.1.7.3 Recent developments
    - 11.1.7.3.1 Product launches and approvals
    - 11.1.7.3.2 Deals
    - 11.1.7.3.3 Expansions
    - 11.1.7.3.4 Other developments
- 11.1.8 BIOCON
  - 11.1.8.1 Business overview
  - 11.1.8.2 Products offered
  - 11.1.8.3 Recent developments
    - 11.1.8.3.1 Deals
    - 11.1.8.3.2 Other developments
- 11.1.9 ROCHE DIABETES CARE
  - 11.1.9.1 Business overview
  - 11.1.9.2 Products offered
  - 11.1.9.3 Recent developments
    - 11.1.9.3.1 Product launches and approvals
- 11.1.10 HTL-STREFA (SUBSIDIARY OF THE MTD GROUP)
  - 11.1.10.1 Business overview
  - 11.1.10.2 Products offered
  - 11.1.10.3 Recent developments
    - 11.1.10.3.1 Deals
- 11.1.11 YPSOMED
  - 11.1.11.1 Business overview
  - 11.1.11.2 Products offered
  - 11.1.11.3 Recent developments
    - 11.1.11.3.1 Product launches and approvals
    - 11.1.11.3.2 Deals
    - 11.1.11.3.3 Expansions
    - 11.1.11.3.4 Other developments
- 11.1.12 MEDTRUM TECHNOLOGIES INC.
  - 11.1.12.1 Business overview
  - 11.1.12.2 Products offered
- 11.1.13 TERUMO CORPORATION
  - 11.1.13.1 Business overview
  - 11.1.13.2 Products offered
  - 11.1.13.3 Recent developments
    - 11.1.13.3.1 Product launches and approvals
    - 11.1.13.3.2 Deals
    - 11.1.13.3.3 Expansions
    - 11.1.13.3.4 Other developments
- 11.1.14 WOCKHARDT LIMITED
  - 11.1.14.1 Business overview
  - 11.1.14.2 Products offered
  - 11.1.14.3 Recent developments
    - 11.1.14.3.1 Product launches and approvals
    - 11.1.14.3.2 Other developments
- 11.1.15 NIPRO
  - 11.1.15.1 Business overview
  - 11.1.15.2 Products offered
  - 11.1.15.3 Recent developments
    - 11.1.15.3.1 Expansions
11.2 OTHER PLAYERS
- 11.2.1 CEQUR CORPORATION
- 11.2.2 EOFLOW CO., LTD.
- 11.2.3 HINDUSTAN SYRINGES & MEDICAL DEVICES LTD
- 11.2.4 SOOIL DEVELOPMENTS CO., LTD
- 11.2.5 SUNGSHIM MEDICAL CO., LTD.
- 11.2.6 B.BRAUN SE
- 11.2.7 DEBIOTECH SA
- 11.2.8 JIANGSU DELFU MEDICAL DEVICE CO., LTD
- 11.2.9 HASELMEIER (A SUBSIDIARY OF MEDMIX)
- 11.2.10 MANNKIND CORPORATION

12 APPENDIX

12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS

Product Code: MD 5192

List of Tables

TABLE 1 INCLUSION AND EXCLUSIONS
TABLE 2 STANDARD CURRENCY CONVERSION RATES (USD)
TABLE 3 RISK ASSESSMENT: INSULIN DELIVERY DEVICES MARKET
TABLE 4 TOP 10 COUNTRIES/TERRITORIES WITH HIGHEST NUMBER OF ADULTS (20-79 YEARS) WITH DIABETES, 2024 AND 2050 (MILLION)
TABLE 5 TOTAL DIABETES-RELATED HEALTH EXPENDITURE ACROSS REGIONS, 2024 AND 2050 (USD MILLION)
TABLE 6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
TABLE 12 EUROPE: MEDICAL DEVICES, BY CLASS
TABLE 13 EUROPE: CONFORMITY ASSESSMENT
TABLE 14 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODY
TABLE 15 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
TABLE 16 INDIA: MEDICAL DEVICE CLASSIFICATION
TABLE 17 HYBRID CLOSED-LOOP SYSTEMS: CURRENT MARKET SCENARIO
TABLE 18 MAJOR SMART INSULIN PENS AVAILABLE GLOBALLY
TABLE 19 RECENT COLLABORATIONS IN INSULIN DELIVERY DEVICE MARKET
TABLE 20 US: INSULIN DELIVERY DEVICE COVERAGE AND REIMBURSEMENT
TABLE 21 CANADA: INSULIN DELIVERY DEVICE COVERAGE AND REIMBURSEMENT
TABLE 22 UK: INSULIN DELIVERY DEVICE COVERAGE AND REIMBURSEMENT
TABLE 23 AUSTRALIA: INSULIN DELIVERY DEVICES COVERAGE AND REIMBURSEMENT
TABLE 24 OTHER COUNTRIES: INSULIN DELIVERY DEVICE COVERAGE AND REIMBURSEMENT
TABLE 25 INSULIN DELIVERY DEVICES MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025-2026
TABLE 26 INDICATIVE PRICING TREND OF INSULIN DELIVERY DEVICE, BY KEY PLAYER, 2022-2024 (USD)
TABLE 27 INDICATIVE PRICING TREND OF INSULIN DELIVERY DEVICE, BY REGION, 2022-2024 (USD)
TABLE 28 IMPORT DATA FOR INSULIN DELIVERY SYSTEMS (HS CODE: 901839), BY COUNTRY, 2020-2023 (USD THOUSAND)
TABLE 29 EXPORT DATA FOR INSULIN DELIVERY SYSTEMS (HS CODE: 901839), BY COUNTRY, 2020-2023 (USD THOUSAND)
TABLE 30 LIST OF PATENTS IN INSULIN DELIVERY DEVICES MARKET, 2022-2024
TABLE 31 INSULIN DELIVERY DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
TABLE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF END USERS
TABLE 33 KEY BUYING CRITERIA FOR END USERS
TABLE 34 UNMET NEEDS: INSULIN DELIVERY DEVICES MARKET
TABLE 35 END-USER EXPECTATIONS: INSULIN DELIVERY DEVICES MARKET
TABLE 36 INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 37 INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 38 INSULIN PENS MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 39 INSULIN PENS MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 40 REUSABLE INSULIN PENS MARKET, BY COUNTRY, 2022-2024 (USD MILLION)
TABLE 41 REUSABLE INSULIN PENS MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 42 DISPOSABLE INSULIN PENS MARKET, BY COUNTRY, 2022-2024 (USD MILLION)
TABLE 43 DISPOSABLE INSULIN PENS MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 44 INSULIN PUMPS MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 45 INSULIN PUMPS MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 46 TETHERED INSULIN PUMPS MARKET, BY COUNTRY, 2022-2024 (USD MILLION)
TABLE 47 TETHERED INSULIN PUMPS MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 48 TUBELESS INSULIN PUMPS MARKET, BY COUNTRY, 2022-2024 (USD MILLION)
TABLE 49 TUBELESS INSULIN PUMPS MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 50 INSULIN PEN NEEDLES MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 51 INSULIN PEN NEEDLES MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 52 STANDARD INSULIN PEN NEEDLES OFFERED BY KEY PLAYERS
TABLE 53 STANDARD INSULIN PEN NEEDLES MARKET, BY COUNTRY, 2022-2024 (USD MILLION)
TABLE 54 STANDARD INSULIN PEN NEEDLES MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 55 SAFETY INSULIN PEN NEEDLES OFFERED BY KEY PLAYERS
TABLE 56 SAFETY INSULIN PEN NEEDLES MARKET, BY COUNTRY, 2022-2024 (USD MILLION)
TABLE 57 SAFETY INSULIN PEN NEEDLES MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 58 INSULIN SYRINGES MARKET, BY COUNTRY, 2022-2024 (USD MILLION)
TABLE 59 INSULIN SYRINGES MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 60 OTHER INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2022-2024 (USD MILLION)
TABLE 61 OTHER INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 62 INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022-2024 (USD MILLION)
TABLE 63 INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 64 INSULIN DELIVERY DEVICES MARKET FOR TYPE 1 DIABETES, BY COUNTRY, 2022-2024 (USD MILLION)
TABLE 65 INSULIN DELIVERY DEVICES MARKET FOR TYPE 1 DIABETES, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 66 INSULIN DELIVERY DEVICES MARKET FOR TYPE 2 DIABETES, BY COUNTRY, 2022-2024 (USD MILLION)
TABLE 67 INSULIN DELIVERY DEVICES MARKET FOR TYPE 2 DIABETES, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 68 INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022-2024 (USD MILLION)
TABLE 69 INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025-2030 (USD MILLION)
TABLE 70 INSULIN DELIVERY DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION, 2022-2024 (USD MILLION)
TABLE 71 INSULIN DELIVERY DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 72 INSULIN DELIVERY DEVICES MARKET FOR HOSPITALS & CLINICS, BY REGION, 2022-2024 (USD MILLION)
TABLE 73 INSULIN DELIVERY DEVICES MARKET FOR HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 74 INSULIN DELIVERY DEVICES MARKET FOR OTHER END USERS, BY REGION, 2022-2024 (USD MILLION)
TABLE 75 INSULIN DELIVERY DEVICES MARKET FOR OTHER END USERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 76 INSULIN DELIVERY DEVICES MARKET, BY REGION, 2022-2024 (USD MILLION)
TABLE 77 INSULIN DELIVERY DEVICES MARKET, BY REGION, 2025-2030 (USD MILLION)
TABLE 78 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2022-2024 (USD MILLION)
TABLE 79 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 80 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 81 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 82 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 83 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 84 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 85 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 86 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022-2024 (USD MILLION)
TABLE 87 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025-2030 (USD MILLION)
TABLE 88 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022-2024 (USD MILLION)
TABLE 89 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 90 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022-2024 (USD MILLION)
TABLE 91 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025-2030 (USD MILLION)
TABLE 92 US: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 93 US: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 94 US: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 95 US: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 96 US: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 97 US: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 98 US: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022-2024 (USD MILLION)
TABLE 99 US: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025-2030 (USD MILLION)
TABLE 100 US: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022-2024 (USD MILLION)
TABLE 101 US: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 102 US: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022-2024 (USD MILLION)
TABLE 103 US: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025-2030 (USD MILLION)
TABLE 104 ELIGIBILITY FOR INSULIN PUMPS AND SUPPLIES IN CANADA FOR TYPE I DIABETES, 2023
TABLE 105 CANADA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 106 CANADA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 107 CANADA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 108 CANADA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 109 CANADA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 110 CANADA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 111 CANADA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022-2024 (USD MILLION)
TABLE 112 CANADA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025-2030 (USD MILLION)
TABLE 113 CANADA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022-2024 (USD MILLION)
TABLE 114 CANADA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 115 CANADA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022-2024 (USD MILLION)
TABLE 116 CANADA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025-2030 (USD MILLION)
TABLE 117 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2022-2024 (USD MILLION)
TABLE 118 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 119 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 120 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 121 EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 122 EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 123 EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 124 EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 125 EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022-2024 (USD MILLION)
TABLE 126 EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025-2030 (USD MILLION)
TABLE 127 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022-2024 (USD MILLION)
TABLE 128 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 129 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022-2024 (USD MILLION)
TABLE 130 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025-2030 (USD MILLION)
TABLE 131 GERMANY: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 132 GERMANY: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 133 GERMANY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 134 GERMANY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 135 GERMANY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 136 GERMANY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 137 GERMANY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022-2024 (USD MILLION)
TABLE 138 GERMANY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025-2030 (USD MILLION)
TABLE 139 GERMANY: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022-2024 (USD MILLION)
TABLE 140 GERMANY: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 141 GERMANY: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022-2024 (USD MILLION)
TABLE 142 GERMANY: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025-2030 (USD MILLION)
TABLE 143 UK: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 144 UK: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 145 UK: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 146 UK: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 147 UK: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 148 UK: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 149 UK: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022-2024 (USD MILLION)
TABLE 150 UK: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025-2030 (USD MILLION)
TABLE 151 UK: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022-2024 (USD MILLION)
TABLE 152 UK: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 153 UK: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022-2024 (USD MILLION)
TABLE 154 UK: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025-2030 (USD MILLION)
TABLE 155 FRANCE: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 156 FRANCE: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 157 FRANCE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 158 FRANCE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 159 FRANCE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 160 FRANCE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 161 FRANCE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022-2024 (USD MILLION)
TABLE 162 FRANCE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025-2030 (USD MILLION)
TABLE 163 FRANCE: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022-2024 (USD MILLION)
TABLE 164 FRANCE: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 165 FRANCE: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022-2024 (USD MILLION)
TABLE 166 FRANCE: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025-2030 (USD MILLION)
TABLE 167 ITALY: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 168 ITALY: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 169 ITALY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 170 ITALY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 171 ITALY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 172 ITALY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 173 ITALY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022-2024 (USD MILLION)
TABLE 174 ITALY: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025-2030 (USD MILLION)
TABLE 175 ITALY: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022-2024 (USD MILLION)
TABLE 176 ITALY: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 177 ITALY: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022-2024 (USD MILLION)
TABLE 178 ITALY: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025-2030 (USD MILLION)
TABLE 179 SPAIN: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 180 SPAIN: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 181 SPAIN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 182 SPAIN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 183 SPAIN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 184 SPAIN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 185 SPAIN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022-2024 (USD MILLION)
TABLE 186 SPAIN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025-2030 (USD MILLION)
TABLE 187 SPAIN: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022-2024 (USD MILLION)
TABLE 188 SPAIN: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 189 SPAIN: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022-2024 (USD MILLION)
TABLE 190 SPAIN: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025-2030 (USD MILLION)
TABLE 191 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 192 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 193 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 194 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 195 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 196 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 197 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022-2024 (USD MILLION)
TABLE 198 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025-2030 (USD MILLION)
TABLE 199 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022-2024 (USD MILLION)
TABLE 200 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 201 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022-2024 (USD MILLION)
TABLE 202 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025-2030 (USD MILLION)
TABLE 203 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2022-2024 (USD MILLION)
TABLE 204 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 205 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 206 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 207 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 208 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 209 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 210 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 211 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022-2024 (USD MILLION)
TABLE 212 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025-2030 (USD MILLION)
TABLE 213 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022-2024 (USD MILLION)
TABLE 214 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 215 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022-2024 (USD MILLION)
TABLE 216 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025-2030 (USD MILLION)
TABLE 217 CHINA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 218 CHINA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 219 CHINA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 220 CHINA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 221 CHINA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 222 CHINA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 223 CHINA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022-2024 (USD MILLION)
TABLE 224 CHINA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025-2030 (USD MILLION)
TABLE 225 CHINA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022-2024 (USD MILLION)
TABLE 226 CHINA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 227 CHINA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022-2024 (USD MILLION)
TABLE 228 CHINA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025-2030 (USD MILLION)
TABLE 229 JAPAN: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 230 JAPAN: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 231 JAPAN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 232 JAPAN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 233 JAPAN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 234 JAPAN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 235 JAPAN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022-2024 (USD MILLION)
TABLE 236 JAPAN: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025-2030 (USD MILLION)
TABLE 237 JAPAN: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022-2024 (USD MILLION)
TABLE 238 JAPAN: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 239 JAPAN: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022-2024 (USD MILLION)
TABLE 240 JAPAN: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025-2030 (USD MILLION)
TABLE 241 INDIA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 242 INDIA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 243 INDIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 244 INDIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 245 INDIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 246 INDIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 247 INDIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022-2024 (USD MILLION)
TABLE 248 INDIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025-2030 (USD MILLION)
TABLE 249 INDIA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022-2024 (USD MILLION)
TABLE 250 INDIA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 251 INDIA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022-2024 (USD MILLION)
TABLE 252 INDIA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025-2030 (USD MILLION)
TABLE 253 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 254 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 255 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 256 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 257 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 258 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 259 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022-2024 (USD MILLION)
TABLE 260 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025-2030 (USD MILLION)
TABLE 261 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022-2024 (USD MILLION)
TABLE 262 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 263 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022-2024 (USD MILLION)
TABLE 264 AUSTRALIA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025-2030 (USD MILLION)
TABLE 265 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 266 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 267 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 268 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 269 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 270 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 271 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022-2024 (USD MILLION)
TABLE 272 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025-2030 (USD MILLION)
TABLE 273 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022-2024 (USD MILLION)
TABLE 274 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 275 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022-2024 (USD MILLION)
TABLE 276 SOUTH KOREA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025-2030 (USD MILLION)
TABLE 277 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 278 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 279 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 280 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 281 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 282 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 283 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022-2024 (USD MILLION)
TABLE 284 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025-2030 (USD MILLION)
TABLE 285 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022-2024 (USD MILLION)
TABLE 286 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 287 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022-2024 (USD MILLION)
TABLE 288 REST OF ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025-2030 (USD MILLION)
TABLE 289 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2022-2024 (USD MILLION)
TABLE 290 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 291 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 292 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 293 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 294 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 295 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 296 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 297 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022-2024 (USD MILLION)
TABLE 298 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025-2030 (USD MILLION)
TABLE 299 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022-2024 (USD MILLION)
TABLE 300 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 301 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022-2024 (USD MILLION)
TABLE 302 LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025-2030 (USD MILLION)
TABLE 303 BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 304 BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 305 BRAZIL: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 306 BRAZIL: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 307 BRAZIL: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 308 BRAZIL: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 309 BRAZIL: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022-2024 (USD MILLION)
TABLE 310 BRAZIL: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025-2030 (USD MILLION)
TABLE 311 BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022-2024 (USD MILLION)
TABLE 312 BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 313 BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022-2024 (USD MILLION)
TABLE 314 BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025-2030 (USD MILLION)
TABLE 315 MEXICO: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 316 MEXICO: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 317 MEXICO: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 318 MEXICO: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 319 MEXICO: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 320 MEXICO: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 321 MEXICO: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022-2024 (USD MILLION)
TABLE 322 MEXICO: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025-2030 (USD MILLION)
TABLE 323 MEXICO: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022-2024 (USD MILLION)
TABLE 324 MEXICO: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 325 MEXICO: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022-2024 (USD MILLION)
TABLE 326 MEXICO: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025-2030 (USD MILLION)
TABLE 327 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 328 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 329 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 330 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 331 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 332 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 333 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022-2024 (USD MILLION)
TABLE 334 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025-2030 (USD MILLION)
TABLE 335 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022-2024 (USD MILLION)
TABLE 336 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 337 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022-2024 (USD MILLION)
TABLE 338 REST OF LATIN AMERICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025-2030 (USD MILLION)
TABLE 339 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2022-2024 (USD MILLION)
TABLE 340 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 341 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 342 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 343 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 344 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 345 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 346 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 347 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022-2024 (USD MILLION)
TABLE 348 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025-2030 (USD MILLION)
TABLE 349 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022-2024 (USD MILLION)
TABLE 350 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 351 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022-2024 (USD MILLION)
TABLE 352 MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025-2030 (USD MILLION)
TABLE 353 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 354 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 355 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 356 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 357 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 358 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 359 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022-2024 (USD MILLION)
TABLE 360 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025-2030 (USD MILLION)
TABLE 361 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022-2024 (USD MILLION)
TABLE 362 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 363 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022-2024 (USD MILLION)
TABLE 364 GCC COUNTRIES: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025-2030 (USD MILLION)
TABLE 365 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2022-2024 (USD MILLION)
TABLE 366 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025-2030 (USD MILLION)
TABLE 367 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 368 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PENS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 369 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2022-2024 (USD MILLION)
TABLE 370 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PUMPS, BY TYPE, 2025-2030 (USD MILLION)
TABLE 371 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2022-2024 (USD MILLION)
TABLE 372 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET FOR INSULIN PEN NEEDLES, BY TYPE, 2025-2030 (USD MILLION)
TABLE 373 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2022-2024 (USD MILLION)
TABLE 374 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025-2030 (USD MILLION)
TABLE 375 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2022-2024 (USD MILLION)
TABLE 376 REST OF MIDDLE EAST & AFRICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025-2030 (USD MILLION)
TABLE 377 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN INSULIN DELIVERY DEVICES MARKET
TABLE 378 INSULIN DELIVERY DEVICE MARKET: DEGREE OF COMPETITION
TABLE 379 INSULIN DELIVERY DEVICES MARKET: TYPE FOOTPRINT, 2024
TABLE 380 INSULIN DELIVERY DEVICES MARKET: REGION FOOTPRINT, 2024
TABLE 381 INSULIN DELIVERY DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2024
TABLE 382 INSULIN DELIVERY DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2024
TABLE 383 INSULIN DELIVERY DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-APRIL 2025
TABLE 384 INSULIN DELIVERY DEVICES MARKET: DEALS, JANUARY 2022-APRIL 2025
TABLE 385 INSULIN DELIVERY DEVICES MARKET: EXPANSIONS, JANUARY 2022-APRIL 2025
TABLE 386 INSULIN DELIVERY DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2022-APRIL 2025
TABLE 387 EMBECTA CORP.: BUSINESS OVERVIEW
TABLE 388 EMBECTA CORP.: PRODUCTS OFFERED
TABLE 389 EMBECTA CORP: PRODUCTS LAUNCHES & APPROVALS
TABLE 390 EMBECTA CORP: DEALS
TABLE 391 EMBECTA CORP: EXPANSIONS
TABLE 392 EMBECTA CORP.: OTHER DEVELOPMENTS
TABLE 393 NOVO NORDISK A/S: BUSINESS OVERVIEW
TABLE 394 NOVO NORDISK A/S: PRODUCTS OFFERED
TABLE 395 NOVO NORDISK A/S: PRODUCTS LAUNCHES & APPROVALS
TABLE 396 NOVO NORDISK A/S: DEALS
TABLE 397 NOVO NORDISK A/S: OTHER DEVELOPMENTS
TABLE 398 MEDTRONIC: BUSINESS OVERVIEW
TABLE 399 MEDTRONIC: PRODUCTS OFFERED
TABLE 400 MEDTRONIC: PRODUCT LAUNCHES & APPROVALS
TABLE 401 MEDTRONIC: DEALS
TABLE 402 MEDTRONIC: EXPANSIONS
TABLE 403 MEDTRONIC: OTHER DEVELOPMENTS
TABLE 404 SANOFI: BUSINESS OVERVIEW
TABLE 405 SANOFI: PRODUCTS OFFERED
TABLE 406 SANOFI: PRODUCT LAUNCHES & APPROVALS
TABLE 407 SANOFI: EXPANSIONS
TABLE 408 SANOFI: OTHER DEVELOPMENTS
TABLE 409 ELI LILLY AND COMPANY: BUSINESS OVERVIEW
TABLE 410 ELI LILLY AND COMPANY: PRODUCTS OFFERED
TABLE 411 ELI LILLY AND COMPANY: PRODUCTS LAUNCHES
TABLE 412 ELI LILLY AND COMPANY: DEALS
TABLE 413 ELI LILLY AND COMPANY: EXPANSIONS
TABLE 414 ELI LILLY AND COMPANY: OTHER DEVELOPMENTS
TABLE 415 TANDEM DIABETES CARE, INC.: BUSINESS OVERVIEW
TABLE 416 TANDEM DIABETES CARE, INC.: PRODUCTS OFFERED
TABLE 417 TANDEM DIABETES CARE, INC.: PRODUCTS LAUNCHES & APPROVALS
TABLE 418 TANDEM DIABETES CARE, INC.: DEALS
TABLE 419 INSULET CORPORATION: BUSINESS OVERVIEW
TABLE 420 INSULET CORPORATION: PRODUCTS LAUNCHES & APPROVALS
TABLE 421 INSULET CORPORATION: DEALS
TABLE 422 INSULET CORPORATION: EXPANSIONS
TABLE 423 INSULET CORPORATION: OTHER DEVELOPMENTS
TABLE 424 BIOCON: BUSINESS OVERVIEW
TABLE 425 BIOCON: PRODUCTS OFFERED
TABLE 426 BIOCON: DEALS
TABLE 427 BIOCON: OTHER DEVELOPMENTS
TABLE 428 F. HOFFMANN-LA ROCHE: BUSINESS OVERVIEW
TABLE 429 F. HOFFMANN-LA ROCHE: PRODUCTS OFFERED
TABLE 430 HOFFMANN-LA ROCHE LTD.: PRODUCTS LAUNCHES
TABLE 431 HTL-STREFA (SUBSIDIARY OF THE MTD GROUP): BUSINESS OVERVIEW
TABLE 432 HTL-STREFA (SUBSIDIARY OF THE MTD GROUP): PRODUCTS OFFERED
TABLE 433 HTL-STREFA (SUBSIDIARY OF THE MTD GROUP): DEALS
TABLE 434 YPSOMED: BUSINESS OVERVIEW
TABLE 435 YPSOMED: PRODUCTS OFFERED
TABLE 436 YPSOMED: PRODUCT LAUNCHES & APPROVALS
TABLE 437 YPSOMED: DEALS
TABLE 438 YPSOMED: EXPANSIONS
TABLE 439 YPSOMED: OTHER DEVELOPMENTS
TABLE 440 MEDTRUM TECHNOLOGIES INC.: BUSINESS OVERVIEW
TABLE 441 MEDTRUM TECHNOLOGIES INC.: PRODUCT PORTFOLIO
TABLE 442 TERUMO CORPORATION: BUSINESS OVERVIEW
TABLE 443 TERUMO CORPORATION: PRODUCTS OFFERED
TABLE 444 TERUMO CORPORATION: PRODUCT LAUNCHES
TABLE 445 TERUMO CORPORATION: DEALS
TABLE 446 TERUMO CORPORATION: EXPANSIONS
TABLE 447 TERUMO CORPORATION: OTHER DEVELOPMENTS
TABLE 448 WOCKHARDT LIMITED: BUSINESS OVERVIEW
TABLE 449 WOCKHARDT LIMITED: PRODUCTS OFFERED
TABLE 450 WOCKHARDT LIMITED: PRODUCTS LAUNCHES
TABLE 451 WOCKHARDT LIMITED: OTHER DEVELOPMENTS
TABLE 452 NIPRO: BUSINESS OVERVIEW
TABLE 453 NIPRO: PRODUCTS OFFERED
TABLE 454 NIPRO: EXPANSIONS

List of Figures

FIGURE 1 INSULIN DELIVERY DEVICES MARKET SEGMENTATION
FIGURE 2 STUDY YEARS CONSIDERED
FIGURE 3 RESEARCH DESIGN
FIGURE 4 KEY DATA FROM SECONDARY SOURCES
FIGURE 5 PRIMARY SOURCES
FIGURE 6 KEY DATA FROM PRIMARY SOURCES
FIGURE 7 KEY INDUSTRY INSIGHTS
FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 10 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
FIGURE 11 TOP-DOWN APPROACH
FIGURE 12 INSULIN DELIVERY DEVICES MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025-2030)
FIGURE 13 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
FIGURE 14 DATA TRIANGULATION METHODOLOGY
FIGURE 15 INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 16 INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 17 INSULIN DELIVERY DEVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 18 GEOGRAPHICAL SNAPSHOT OF INSULIN DELIVERY DEVICES MARKET
FIGURE 19 INCREASING TECHNOLOGICAL ADVANCEMENTS IN INSULIN DELIVERY DEVICES TO DRIVE MARKET
FIGURE 20 NORTH AMERICA ACCOUNTED FOR LARGEST SHARE OF INSULIN DELIVERY DEVICES MARKET IN 2024
FIGURE 21 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 22 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD (2025-2030)
FIGURE 23 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
FIGURE 24 INSULIN DELIVERY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 25 ESTIMATES OF GLOBAL PREVALENCE OF DIABETES IN 20-79-YEAR AGE GROUP, 2011-2024 (MILLION)
FIGURE 26 DIABETES AGE-STANDARDIZED PREVALENCE IN PEOPLE (65-99 YEARS), BY REGION, 2024 AND 2050 (MILLION)
FIGURE 27 ADVANCEMENTS IN INSULIN DELIVERY DEVICES
FIGURE 28 FDA 510(K) APPROVAL PROCESS
FIGURE 29 EUROPE: CE MARK APPROVAL PROCESS FOR INSULIN DELIVERY DEVICES
FIGURE 30 SUMMARY OF APPROVAL, ACCESS, AND DISTRIBUTION PATHWAYS FOR NEW TECHNOLOGY USED FOR INSULIN DRUG DELIVERY DEVICES
FIGURE 31 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR INSULIN DELIVERY DEVICES MARKET, JANUARY 2014-DECEMBER 2024
FIGURE 32 TOP PATENT APPLICANT COUNTRIES FOR INSULIN DELIVERY DEVICES, JANUARY 2014-DECEMBER 2024
FIGURE 33 INSULIN DELIVERY DEVICE MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 34 INSULIN DELIVERY DEVICE: VALUE CHAIN ANALYSIS
FIGURE 35 INSULIN DELIVERY DEVICE MARKET: ECOSYSTEM MAPPING
FIGURE 36 INSULIN DELIVERY DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 37 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF END USERS
FIGURE 38 KEY BUYING CRITERIA FOR END USERS
FIGURE 39 INSULIN DELIVERY DEVICES MARKET: ADJACENT MARKET ANALYSIS
FIGURE 40 INVESTMENT/VENTURE CAPITAL SCENARIO IN INSULIN DELIVERY DEVICES, 2021-2023 (USD MILLION)
FIGURE 41 INSULIN DELIVERY DEVICES MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 42 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET SNAPSHOT
FIGURE 43 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET SNAPSHOT
FIGURE 44 REVENUE SHARE ANALYSIS OF KEY PLAYERS, 2022-2024 (USD MILLION)
FIGURE 45 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024
FIGURE 46 INSULIN DELIVERY DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 47 INSULIN DELIVERY DEVICES MARKET: COMPANY FOOTPRINT, 2024
FIGURE 48 INSULIN DELIVERY DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 49 INSULIN DELIVERY DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 50 EV/EBITDA OF KEY VENDORS, 2024
FIGURE 51 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2024
FIGURE 52 R&D ASSESSMENT OF KEY PLAYERS
FIGURE 53 EMBECTA CORP.: COMPANY SNAPSHOT, 2024
FIGURE 54 NOVO NORDISK A/S: COMPANY SNAPSHOT, 2024
FIGURE 55 MEDTRONIC: COMPANY SNAPSHOT, 2024
FIGURE 56 SANOFI: COMPANY SNAPSHOT, 2024
FIGURE 57 ELI LILLY AND COMPANY: COMPANY SNAPSHOT, 2024
FIGURE 58 TANDEM DIABETES CARE, INC.: COMPANY SNAPSHOT, 2024
FIGURE 59 INSULET CORPORATION: COMPANY SNAPSHOT, 2024
FIGURE 60 BIOCON: COMPANY SNAPSHOT, 2024
FIGURE 61 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT, 2024
FIGURE 62 YPSOMED: COMPANY SNAPSHOT, 2024
FIGURE 63 TERUMO CORPORATION: COMPANY SNAPSHOT, 2024
FIGURE 64 WOCKHARDT LIMITED: COMPANY SNAPSHOT, 2024
FIGURE 65 NIPRO: COMPANY SNAPSHOT, 2024

Insulin Delivery Device Market by Type (Insulin Pens (Reusable, Disposable), Insulin Pumps (Tethered, Tubeless), Insulin Pen Needle (Standard, Safety), Insulin Syringes, Others), Disease Type (Type 1 Diabetes, Type 2 Diabetes) - Global Forecast to 2030

Description

Table of Contents

List of Tables

A breakdown of the primary participants referred to for this report is provided below:

This report provides insights on the following pointers:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 INSULIN DELIVERY DEVICES MARKET, BY TYPE

7 INSULIN DELIVERY DEVICES MARKET, BY DISEASE TYPE

8 INSULIN DELIVERY DEVICES MARKET, BY END USER

9 INSULIN DELIVERY DEVICES MARKET, BY REGION

10 COMPETITIVE LANDSCAPE

11 COMPANY PROFILES

12 APPENDIX

List of Tables

List of Figures